These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36049426)

  • 1. Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptide.
    Jing R; Wang Q; Chen L; Li G; Li R; Zhang L; Zhang H; Zuo B; Seow Y; Qiao X; Wang B; Xu J; Chen J; Song T; Yin H
    Biomaterials; 2022 Oct; 289():121758. PubMed ID: 36049426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro.
    Jing R; Zhou X; Zhao J; Wei Y; Zuo B; You A; Rao Q; Gao X; Yang R; Chen L; Lu Z; Zhou Q; Zhang N; Yin H
    Hepatology; 2018 Oct; 68(4):1391-1411. PubMed ID: 29405333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired gap junctions in human hepatocellular carcinoma limit intrinsic oxaliplatin chemosensitivity: A key role of connexin 26.
    Yang Y; Zhu J; Zhang N; Zhao Y; Li WY; Zhao FY; Ou YR; Qin SK; Wu Q
    Int J Oncol; 2016 Feb; 48(2):703-13. PubMed ID: 26648344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
    Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
    Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
    Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
    Wang X; Liu Y; Qin Q; Zheng T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis.
    Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
    J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
    Huang H; Chen J; Ding CM; Jin X; Jia ZM; Peng J
    J Cell Mol Med; 2018 Jun; 22(6):3238-3245. PubMed ID: 29602203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
    Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma.
    Feng S; Zhou J; Li Z; Appelman HD; Zhao L; Zhu J; Wang TD
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110498. PubMed ID: 31536939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
    Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
    Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
    Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
    Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
    Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
    Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
    Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma.
    Tan Y; Zheng J; Liu X; Lu M; Zhang C; Xing B; Du X
    Biochem Biophys Res Commun; 2018 May; 499(4):1032-1038. PubMed ID: 29634924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.